BOVILIS Covexin Plus (Canada)

This treatment applies to the following species:

Company: Merck Animal Health

Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Tetani-Perfringens Types C & D Bacterin-Toxoid

Cattle Vaccine

BOVILIS Covexin Plus Indications

This product has been shown to be effective for the vaccination of healthy cattle against disease caused by Clostridium chauvoei, C. septicum, C. haemolyticum, C. novyi, C. sordellii, C. tetani, and C. perfringens Type C & D. This product was licensed prior to the requirement to establish a minimum age for use. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Although C. perfringens Type B is not a significant problem in North America, immunity is derived from a combination of the Type C (beta) and Type D (epsilon) fractions.

ADMINISTRATION AND DOSAGE: Mix gently. Inject 2 mL subcutaneously followed by a 2 mL dose in 3 weeks. Calves vaccinated at 3-6 months of age should be given a 3^rd vaccination with either this vaccine, or another vaccine containing C. perfringens Type D epsilon toxoid. For advice on revaccination frequency, contact your veterinarian.

PRESERVATIVES: Gentamicin and thimerosal.

Precautions

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions. Transient swelling may occur post-vaccination.

BOVILIS Covexin Plus Caution

Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant animals. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

In case of human exposure, contact a physician.

FOR ANIMAL USE ONLY.

Manufactured by:

Schering-Plough Animal Health Limited, Upper Hutt, New Zealand

For:

Intervet Canada Corp., Kirkland, Québec H9H 4M7

1 866 683-7838 (Canada)

VPN 311

PCN 7340.00

			Code
20 mL	10 Doses	2 mL per dose	058049	999013 R1 360597 R5
100 mL	50 Doses		058046	370097 R2 373929 R4
250 mL	125 Doses		058051	383152 R2 399506 R5

CPN: 1208335.0

MERCK ANIMAL HEALTH
Intervet Canada Corp.
16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7

Order Desk:		514-428-7013
Toll-Free:		866-683-7838
Fax:		Toll-free 888-498-4444; local 514-428-7014
Website:		www.merck-animal-health.ca

THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.